Monday brought a different energy to the group chat. Some investors popped champagne while others winced at their screens, and honestly neither camp saw it all coming.

Read on to see which headlines moved the most money, and which one is making more than a few CEOs sweat.

Data Center Surge (Sponsored)

One chatbot question, and a server warehouse somewhere in America draws on the grid. Scale that across hundreds of millions of people daily.

Name the stock by text.

Data centers used 4.4% of U.S. electricity in 2023, per Lawrence Berkeley National Laboratory. Its 2028 projection: up to 12%.

Send the ticker and story.

Close to a tripling in five years, on a grid that was not built for it. One company sits right where that power comes from.

Which energy company is it?

*This ad is sent on behalf of Guardian Financial Publishing LLC, doing business as Stable Financial Publishing, 1013 Centre Road Suite 403-D, Wilmington, DE 19805. Nothing here is investment, financial, legal, or tax advice, and it is not a recommendation or solicitation to buy or sell any security. Investing involves substantial risk, including loss of principal; past performance does not guarantee future results. Data-center electricity figures are third-party estimates and projections, and AI IPO timing reflects investor expectations, not company guidance. References to OpenAI, Anthropic and Lawrence Berkeley National Laboratory are for informational purposes only; Stable Financial Publishing is not affiliated with, endorsed by, or sponsored by OpenAI, Anthropic or Lawrence Berkeley National Laboratory. Stable Financial Publishing, its owners, employees and contributors may hold positions in securities mentioned and may trade them at any time. Privacy: https://guardian.pub/privacy-policy/ · Terms: https://guardian.pub/terms-of-service/

Markets

Anthropic made its IPO paperwork public, targeting a Nasdaq debut under the ticker ANT as soon as the week before Thanksgiving, and the filing helped calm AI-bubble jitters.

The filing also revealed that founders could keep control of most shareholder votes for decades. Nvidia, AMD and Broadcom gained about 3%, and the same three chipmakers signaled interest in up to $5 billion of Meta’s coming stock sale.

DoorDash is reportedly in advanced talks to buy Instacart, sending Instacart higher and DoorDash lower.

JetBlue shares tumbled as high fuel prices threatened its turnaround, and Harley-Davidson’s LiveWire spinoff named a chief restructuring officer after its CEO resigned.

Brent crude slipped to about $110. Alphabet and Microsoft report Wednesday, Amazon follows Thursday, and the Fed is expected to hold rates steady.

  • DJIA [+0.28%]

  • S&P 500 [+0.70%]

  • Nasdaq [+0.82%]

  • Russell 2000 [+0.38%]

Market-Moving News

Software & AI

Microsoft is offering voluntary buyouts to approximately 60,000 employees, with eligible workers across four countries receiving departure offers as the company reshapes its workforce while expanding AI investment; actual departures will depend on employee participation.

Amazon’s cloud business could deliver stronger profitability than Wall Street expects, according to UBS’s new forecast of a 46% AWS operating margin in 2027, compared with consensus estimates of 38%, ahead of Thursday’s quarterly results.

Energy & Resources

Eni completed the sale of its Nigerian subsidiary Agip Energy and Natural Resources to APEX, divesting onshore and shallow-water oil and gas operations as the Italian energy producer continues selling assets outside its strategic priorities.

EQT agreed to acquire Range Resources in an approximately $13 billion all-stock transaction, combining two major Appalachian natural-gas producers to serve growing LNG export and electricity demand, with completion expected in the first quarter of 2027.

Finance & Markets

S&P Global’s index business partnered with Kalshi to expand into prediction markets, licensing benchmarks for event contracts and developing new indexes using prediction-market data covering economic, political, and sporting outcomes.

Apollo agreed to acquire a minority stake in Mubadala Capital, expanding its relationship with the Abu Dhabi investment group, with Apollo and additional strategic investors expected to commit a combined $5 billion to the manager’s investment strategies.

Elite Picks (Sponsored)

This report focuses on a narrow group of stocks identified through a detailed screening process.

Analysts apply a combination of metrics to narrow down potential opportunities.

Past selections have shown strong momentum, but no outcomes are guaranteed.

The newest edition is now open for access.

Get the report now.

*This free resource is being sent by Zacks. We identify investment resources you may choose to use in making your own decisions. Use of this resource is subject to the Zacks Terms of Service.
*Past performance is no guarantee of future results. Investing involves risk. This material does not constitute investment, legal, accounting, or tax advice. Zacks Investment Research is not a licensed dealer, broker, or investment adviser.

Healthcare & Biotech

Merck’s experimental cancer drug reduced the risk of death by 32% versus chemotherapy, with new Phase 3 results showing longer survival in previously treated endometrial cancer patients. Median survival reached 19 months, compared with 12.1 months for chemotherapy.

Surgery Partners agreed to a $5.7 billion acquisition by HealthSpan Partners, offering public shareholders $23.50 per share. Bain Capital will retain an ownership interest by rolling its existing stake into the acquiring company.

Transportation & Logistics

Aurora signed a preliminary agreement covering up to 500 driverless trucks for Charger Logistics, with deliveries planned across 2027 and 2028. The nonbinding agreement would expand Charger’s autonomous freight operations, subject to a final contract.

FedEx appointed AutoZone finance chief Jamere Jackson as its next chief financial officer, setting November 30 as his start date. Jackson will replace interim CFO Claude Russ, filling the permanent position following FedEx Freight’s separation.

Top Winners and Losers

Surgery Partners [SGRY] $23.25 (+47.62%)

Surgery Partners got a buyout offer it could not refuse. HealthSpan Partners agreed to take the surgical centers operator private for $23.50 a share in cash, a roughly $5.7 billion deal expected to close in the first quarter of 2027.

Shares sprinted to within pennies of the offer price. Stocks rarely get a cleaner finish line than a signed check.

GrafTech International [EAF] $10.65 (+25.15%)

GrafTech’s graphite electrodes just had a charm offensive.

Third-quarter sales beat expectations at roughly $140 million, the Monterrey plant closure should trim annual costs, and management said it has hit an inflection point on pricing.

Investors who already liked Friday’s rally came back for seconds, and the stock tacked on another big gain on top of Friday’s.

Rapid7 [RPD] $17.93 (+20.25%)

Rapid7 closed about 20% higher with no single headline to point at, which leaves the numbers to do the talking. The cybersecurity company finished near $18, far above the roughly $12 average analyst target.

Software names have been catching bids as AI-disruption fears fade, so perhaps the crowd is simply voting with its wallets this time.

XP Inc. [XP] $15.70 (-48.36%)

XP bet big on a Brazilian victory for Flavio Bolsonaro, and the voters had other plans. Lula’s surprise re-election sent the brokerage’s shares to a new 52-week low in a historic Brazilian sell-off. As a platform that lives on trading commissions, it feels every wobble in local markets. Analysts still see far higher targets, but investors want proof.

PicPay [PICS] $8.78 (-36.38%)

PicPay, the Brazilian digital bank that went public in January at $19, got an unwelcome election surprise. Lula’s win rattled Brazilian assets, and shares of the newcomer slid to less than half the IPO price.

Fintechs aimed at everyday Brazilian consumers are especially sensitive to worries about borrowing costs. This was not a soft landing.

Oric Pharmaceuticals [ORIC] $8.96 (-32.00%)

Oric got caught in the crosshairs at a cancer conference. Johnson & Johnson showed early prostate cancer data for JNJ-6143, a rival to Oric’s lead drug rinzimetostat, which is in a late-stage trial.

Analysts called it a bigger threat, though J&J’s study is small and early. Investors chose to sell first and read the fine print later.

Market-on-close orders must typically be submitted by what time before the 4pm bell to be included in the NYSE's closing auction?

Login or Subscribe to participate

December Eight Matters (Sponsored)

One analyst says Elon Musk is preparing the biggest project of his career, and that December 8 is the date to watch.

See what Elon filed before December 8

James Altucher lays out the filings, the one company he believes sits at the center of it, and the move he thinks matters before December 9.

The company at the center of the plan.

Watch the free Millionaire Maker Masterclass

Everything Else

That's it for today! Please, write us back, and let us know what you think of the Closing Bell Roundup. We're always eager to hear feedback!

Thanks for reading. I'll see you at the next open! 

Best Regards,
— Adam G.
Elite Trade Club

Click here to get our daily newsletter straight to your cell for free.

P.S. Just like this newsletter, it's 100% free*, and you can stop at any time by replying STOP.